Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

Share Price is delayed by 15 minutes
Get Live Data
808.00    -10.00 (-1.22%)
Bid:
811.00
Ask:
813.00
Spread: 2.00 (0.247%)
Market Cap: £1.12b
SVS Live PriceLast checked at - London Stock Exchange

Intraday Savills Share Chart

AGM Statement

15 May 2024 10:02

RNS Number : 5406O
Savills PLC
15 May 2024
 

 

15 May 2024

SAVILLS PLC

("Savills" or "the Company")

Trading update

 

Ahead of its Annual General Meeting (AGM) to be held at 12 noon today at Savills, 33 Margaret Street, London W1G 0JD, Savills plc, the international real estate advisor issues the following trading update:

 

For the year to date, Savills has traded in line with expectations and comfortably ahead of the comparable period last year.

 

Highlights:

 

· Whilst global capital transaction activity is improving, volumes remain subdued ; however values have adjusted in some markets such as the UK and are recalibrating elsewhere.

· Leasing markets have remained more resilient across most sectors, although office take up remains heavily skewed to prime stock with strong sustainability credentials which continues to drive rental growth.

· Most prime residential markets have remained resilient with volumes traded marginally lower than last year, as expected .

· Savills' less transactional businesses have performed in line with expectations, underpinning our overall performance.

· As previously indicated, H1 2024 will be impacted by the ongoing recalibration of values but underlying activity levels are improving, and we continue to expect progressive improvement in the second half of the year as market recovery takes hold.

 

Mark Ridley, Chief Executive, commented:

 

"I am delighted with the performance of our teams worldwide in helping clients facing challenging circumstances and in seeking longer term business development initiatives, which our strong balance sheet enables us to pursue. The strength of our less transactional businesses continues to underpin our performance overall and we continue to anticipate progressively improving volumes through the second half of the year."

 

Trading Update

 

In the Asia Pacific region, Vietnam, Japan and Korea have traded well. We have increased market share again in Hong Kong, albeit off small volumes and markets are correcting to the prevailing level of interest rates. Our substantial Property and Facilities Management business in the region continues to perform well.

 

In the UK, we have continued to perform well, and we have maintained market share gains made in 2023 in prime transactional markets. This has mitigated the impact of reduced transaction volumes compared with the same period last year. Meanwhile, our less transactional service lines have performed in line with our expectations. During the period we have bolstered our WorkThere flexible office advisory business with the acquisition of Situu, a largely landlord-facing flex advisory business.

 

 

Overall, our Continental Europe and Middle East (CEME) business has shown marginal improvement year on year in line with our expectations. Savills is highly dependent upon transactional activity in CEME where capital transaction volumes, particularly in the major markets of Germany and France, remain very compromised. Leasing momentum is a little stronger due to demand for prime stock. In the Middle East market conditions are much stronger and we have grown our Prime Residential brokerage in UAE during the period. In addition, we raised our equity stake in Riviera Estates, a prime residential business in the South of France, to 75%.

 

In North America, where the Group is substantially dependent upon leasing activity by corporate occupiers, our business performance has been in line with our expectations and substantially improved year-on-year. We have concluded a number of significant "HQ" type transactions and continue to take advantage of dislocation in the markets with the hiring of individuals and teams in Canada and the more active markets of Texas and Florida.

 

Savills Investment Management has traded in line with our expectations in an environment which remains challenging for the deployment of equity capital as valuations continue to adjust. We have successfully held first closes on two new funds; an equity fund and Registered Provider focused on the UK affordable homes sector and a pan European whole loan debt fund, both benefiting from initial seed capital from Samsung.

 

Outlook

 

Savills has traded in line with our expectations for the period to date and comfortably ahead of the same period last year. Our less transactional businesses continue to provide a solid platform for the Group with a resilient earnings stream

 

There remains significant investor interest in the secure income characteristics of real estate, where pricing has corrected sufficiently. While we have yet to see a significant amount of re-financing driven activity, we do expect that to increase through the second half of the year. Meanwhile occupiers are clearly focused on improving the sustainability characteristics of their portfolios as well as creating environments in which their work forces can thrive.

 

We continue to develop our business through selective recruitment and acquisitions supported by a strong balance sheet and we maintain our expectation of continued improvement in market conditions through the second half of the year.

 

We anticipate announcing the Group's Half Year Results for the six months to 30 June on 8 August 2024.

 

For further information, contact:

 

Savills 020 7409 8934

Mark Ridley, Group Chief Executive

Simon Shaw, Group Chief Financial Officer

 

Teneo 020 7353 4200

Elizabeth Snow

Jo Blackshaw

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMFIFIAEIIELIS
Date   Source Headline
1st Oct 202511:00 amRNSTotal Voting Rights
29th Sep 202512:09 pmRNSDirector Declaration
25th Sep 20257:00 amRNSDirectorship Change
11th Sep 202512:38 pmRNSDirector/PDMR Shareholding
5th Sep 20252:00 pmRNSAdditional Listing
14th Aug 20257:00 amRNSHalf-year Report
12th Aug 20252:39 pmRNSDirector/PDMR Shareholding
1st Aug 20253:41 pmRNSHolding(s) in Company
21st Jul 20252:03 pmRNSBlock listing Interim Review
16th Jul 20251:44 pmRNSHolding(s) in Company
15th Jul 20254:20 pmRNSHolding(s) in Company
14th Jul 20251:14 pmRNSHolding(s) in Company
14th Jul 202510:18 amRNSDirector/PDMR Shareholding
1st Jul 20257:00 amRNSTotal Voting Rights
30th Jun 20255:20 pmRNSDirector/PDMR Shareholding
23rd Jun 20252:45 pmRNSHolding(s) in Company
20th Jun 20254:00 pmRNSAdditional Listing
12th Jun 20258:15 amRNSDirector/PDMR Shareholding
12th Jun 20258:10 amRNSDirector/PDMR Shareholding
10th Jun 20255:57 pmRNSDirector/PDMR Shareholding
4th Jun 202512:12 pmRNSHolding(s) in Company
2nd Jun 20253:05 pmRNSHolding(s) in Company
2nd Jun 20258:58 amRNSHolding(s) in Company
22nd May 20255:31 pmRNSHolding(s) in Company
15th May 20254:06 pmRNSHolding(s) in Company
14th May 20252:38 pmRNSResult of AGM
14th May 20257:00 amRNSAGM Statement
13th May 20254:01 pmRNSDirector/PDMR Shareholding
29th Apr 20257:00 amRNSSavills Announces Succession Plan
7th Apr 20254:18 pmRNSAnnual Report and AGM Notice
1st Apr 202511:00 amRNSTotal Voting Rights
24th Mar 20252:18 pmRNSHolding(s) in Company
21st Mar 20253:00 pmRNSAdditional Listing
20th Mar 20259:21 amRNSDirector/PDMR Shareholding
18th Mar 20252:27 pmRNSHolding(s) in Company
13th Mar 20257:00 amRNSFinal Results
12th Mar 202511:00 amRNSDirector/PDMR Shareholding
17th Feb 20254:43 pmRNSBlock listing Interim Review
12th Feb 202511:10 amRNSDirector/PDMR Shareholding
11th Feb 20252:32 pmRNSHolding(s) in Company
7th Feb 20253:51 pmRNSHolding(s) in Company
3rd Feb 202511:00 amRNSTotal Voting Rights
29th Jan 20252:28 pmRNSHolding(s) in Company
28th Jan 20253:47 pmRNSHolding(s) in Company
22nd Jan 202511:47 amRNSBlock listing Interim Review
16th Jan 20257:00 amRNSYear End Trading Update
13th Jan 20252:35 pmRNSDirector/PDMR Shareholding
2nd Jan 20253:00 pmRNSTotal Voting Rights
16th Dec 20244:03 pmRNSHolding(s) in Company
12th Dec 202411:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.